Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Serenex and CHDI enter agreement to evaluate Hsp90 inhibitors for Huntington's disease

Jan. 23, 2008

StemCells reports death of patient in phase I clinical trial of HuCNS-SC for NCL

Jan. 23, 2008

Novel SMN2 promoter activator by deCODE may be useful in SMA

Jan. 23, 2008

Positive clinical trial results for epilepsy drug rufinamide in mood disorders

Jan. 23, 2008

Novel analgesic agents imparted in recent Vertex and Merck Frosst patents

Jan. 23, 2008

Studies find little benefit of add-on lamotrigine in refractory schizophrenia patients

Jan. 23, 2008

Preclinical characterization of aripiprazole shows uniqueness of D2 partial agonists

Jan. 22, 2008

Senexis secures new funding to develop innovative compounds for AD

Jan. 22, 2008

Recent Sia Peptides patent discloses new stress-relieving agents

Jan. 21, 2008

FDA places clinical hold on YM BioSciences' phase II AP5 study of AeroLEF for pain

Jan. 21, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...